Departmental Seminar – April 29, 2016

Seminar Series: Spring 2016 ~~ Friday, April 29, 2016

2:00-3:00 PM

              

“Mechanisms and Therapeutic Vulnerabilities of IDH Mutant Biliary Cancer

 

Nabeel Bardeesy, PhD
Associate Professor of Medicine, Harvard Medical School
Assistant Geneticist, Center for Cancer Research
Massachusetts General Hospital

 

Location & Time:
670 Albany Street
Lobby Level #107/108
2:00-3:00 PM


Friday, April 29, 2016
Target Audience: Faculty, Students, Residents, Greater Boston Scientific Community (advertised in MIT’s Bulletin).

At the conclusion of this activity participants will be able to: 1) recall that alterations in cell metabolism can drive cancer growth; 2) state that defining such alterations can lead to new therapeutic approaches and; 3) identify that this knowledge will help physicians understand the biological effects of newly discovered mutations in cancer genes that alter cell metabolism and give them insight into how metabolism can be targeted therapeutically.

               

Course Director: Barbara Slack, PhD

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.